C
opper is an essential element for life, and maintaining its proper homeostasis is critical for the growth, development, and fitness of living organisms (1) (2) (3) (4) (5) (6) (7) . Indeed, loss of copper homeostasis in the body has severe consequences owing to its potent redox activity, which, if uncontrolled, can lead to aberrant oxidative and nitrosative stress events that accompany diseases ranging from cancer (8) to cardiovascular disorders (9-11) to Alzheimer's and related neurodegenerative diseases (4, (12) (13) (14) (15) (16) (17) (18) . Moreover, genetic inactivation of the obligatory copper-handling proteins ATP7A, ATP7B, and SCO1/2 results in serious afflictions (19) of copper deficiency (Menkes disease) (20, 21), copper overload (Wilson disease) (14, 22) , and mitochondrial dysfunction (23), respectively, which can be lethal if left untreated.
Given the central importance of copper to human health and disease, creation of technologies that allow selective and sensitive monitoring of exchangeable copper stores in living systems can help disentangle the global physiological and/or pathological consequences of copper regulation (4, (24) (25) (26) . To meet this goal, our laboratory and others have devised small-molecule (27-35), protein (36, 37), and nucleic acid (38, 39) fluorescent sensors for visualizing labile copper pools in biological contexts. Such chemical tools have provided fundamental insights into the biology of copper, including calcium-dependent copper translocation in neurons (32), antimicrobial behavior of copper surfaces (40, 41), as well as prioritization of mitochondrial copper pools in patient cells with synthesis of cytochrome c oxidase (SCO) mutations (33). However, these studies have been largely limited to dissociated cell cultures and other thin specimens owing to the need for ultraviolet or visible wavelength excitation. As such, the translation of copper detection methodologies to in vivo imaging in mammalian models of health and disease remains a significant and difficult challenge.
We now report the synthesis, spectroscopic properties, and biological imaging applications of Coppersensor 790 (CS790), a first-generation fluorescent sensor for visualizing exchangeable copper stores in living animals. CS790 exhibits a selective and sensitive turn-on response to Cu þ and features near-IR excitation and emission profiles ideal for penetration through thicker biological specimens. Moreover, we establish the ability of CS790 to monitor fluctuations in labile copper levels in living cells, and demonstrate that this chemical tool can be used to detect exchangeable copper stores in living mice under basal, copper-overload, or copper-deficient conditions. Finally, we apply CS790 imaging to interrogate aberrant copper accumulation in a murine model of Wilson disease, highlighting the potential diagnostic value of this technology. Taken together, these data provide a starting point for using molecular imaging to explore the chemistry and biology of copper at the in vivo level.
Results and Discussion
Design and Synthesis of CS790. In designing a turn-on fluorescent sensor for in vivo copper detection, we sought to utilize a photoinduced electron transfer (PET) mechanism for copper sensing on a dye scaffold compatible with live-animal imaging. For the latter, we chose a cyanine 7 (Cy7) dye as the optical reporter. This fluorophore platform possesses near-IR absorption and emission profiles to maximize tissue penetration of the fluorescent signal from the dye while minimizing native tissue autofluorescence, in addition to being biologically inert, nontoxic, and compatible with aqueous media (42, 43). Moreover, related probes for nitric oxide and pH show that the fluorescence properties of Cy7-type dyes can be modulated by PET (44-49). As such, we reasoned that installing an electron-rich 9-aza-2,6,13-trithiapentadecane receptor in appropriate proximity to a Cy7 scaffold would produce a sensor that is responsive to Cu þ , the dominant oxidation state for this metal in cells. As indicated in previous reports, utilization of a soft sulfur-rich receptor provides an appropriate Pearson acidbase match for the soft Cu þ ion (27, 28, 31-33, 50, 51). Fig. 1 summarizes the synthesis of CS790 from the convergent coupling of appropriately derivatized Cy7 and receptor building blocks.
Spectroscopic Characterization of CS790. Initial spectroscopic characterization of CS790 verified a shift in excitation and emission profiles from the visible region to the near-IR window, with maximal absorption of apo and Cu þ -bound CS790 centered at 760 nm ( Fig. S1 ) and maximal emission centered at 790 nm (Fig. 2) . In response to Cu þ , CS790 shows a 15-fold enhancement in fluorescence intensity (Fig. S1 ), corresponding to a quantum yield increase from Φ ¼ 0.0042 for the apo dye to Φ ¼ 0.072 for the copper-bound sensor. Binding analysis using the method of continuous variation (Job's plot, Fig. 2 ) establishes a 1∶1 binding stoichiometry between CS790 and Cu þ with an apparent dissociation constant (K d ) of 3.0 × 10 −11 M (Fig. S1 ). Importantly, selectivity tests with various biologically relevant metals indicate that CS790 does not give false positives to other metals at cellular concentrations, nor do these metals interfere with the Cu þ -triggered turn-on response (Fig. 2) . Additionally, the fluorescent emissions of apo and Cu þ -bound CS790 are stable over the physiological pH range, with a pK a < 2.0 for apo CS790 (Fig. S1 ). The unique combination of near-IR excitation/emission profiles on a biologically compatible fluorophore platform, a robust turn-on response, as well as the tight, sensitive, and selective binding of Cu þ , presage the successful application of CS790 for detection of labile copper stores in living systems.
CS790AM Detects Changes in Labile Copper Levels in Living Cells. Following characterization of the spectroscopic properties of CS790, we sought to apply this sensor to image fluctuations in exchangeable copper pools in living cells. As live cells possess highly lipophilic membranes, we transformed the carboxy groups of CS790 into acetoxymethyl esters to form CS790AM (Fig. 1) , which, unlike CS790, is able to accumulate within cells (52, 53) (Fig. S2) . Once inside the cell, CS790AM is de-esterified by intracellular esterases to produce CS790 (Fig. S3) . Unveiling of the negatively charged carboxylates helps trap CS790 within the cell, as demonstrated by the limited loss of fluorescent signal in HEK 293Tcells over an hour (Fig. S4) . After performing this initial characterization of CS790AM, we utilized two complementary techniques, flow cytometry and confocal microscopy, for CS790-based copper detection in living cells. Flow cytometry experiments in HEK 293T cells reveal a marked shift in population distribution from low fluorescence intensity to high fluorescence intensity when cells are supplemented with copper salts (Fig. 3) . Moreover, treatment of copper-supplemented cells with a copper chelator, tris [2(ethylthio) ethyl]amine (NS3′), reverted the cells to a low fluorescent intensity population. Taken together, the data establish the capacity of CS790AM to detect fluctuations in labile copper levels in living cells and demonstrate that this sensor can monitor both increases and decreases in exchangeable copper in a reversible manner.
With flow cytometry data in hand, CS790AM was used for confocal imaging experiments to further verify its capabilities to detect intracellular exchangeable copper and provide subcellular spatial resolution. In agreement with the flow cytometry results, CS790AM-stained HEK 293T cells show a low intracellular fluorescence, whereas their copper-supplemented counterparts display a marked increase in fluorescence (Fig. 3) . In addition, treatment of copper-supplemented cells with NS3′ restores intracellular fluorescence to baseline levels, again consistent with reversible Cu þ binding to the sensor.
CS790AM Visualizes Dynamic Changes in Exchangeable Copper Stores
in Living Mice. We next sought to apply CS790AM to the in vivo monitoring of labile copper stores in living mice. These experiments utilized a sensitive CCD camera to image mice under basal conditions, as well as during copper overload or depletion. Initial studies focused on five different treatment conditions, aiming to establish the ability of CS790AM to detect fluctuations of exchangeable copper pools in hairless SKH-1 mice. First, we verified the low level of autofluorescence from mice following near-IR excitation by imaging mice injected with vehicle alone (Fig. 4) . Then, to determine the basal level of signal from CS790AM in vivo, mice were treated with CS790AM and the fluorescence output was monitored 5 min after dye injection (Fig. 4) . In vivo copper detection by CS790AM was established using a third group of mice, which was treated with 5 mg∕kg CuCl 2 prior to treatment with CS790AM. Importantly, CuCl 2 was injected 2 h before CS790AM to allow adequate time for absorption of Cu 2þ into tissues and its reduction to Cu þ (54). In mice pretreated with CuCl 2 , we observe a ca. 60% increase in fluorescence relative to control mice, establishing that CS790AM can detect increases in exchangeable Cu þ in living mice (Fig. 4) . Alternatively, mice treated with 5 mg∕kg Cu 2þ immediately prior to CS790AM show no significant increases in fluorescence compared to control mice treated with CS790AM alone (Fig. S5) , providing evidence that the fluorescence increase observed with copper pretreatment is due to detection of Cu þ generated from the reducing cellular environment. To determine the reversibility of copper binding in vivo, we utilized CS790AM imaging in mice injected with 5 mg∕ kg CuCl 2 as well as 5 mg∕kg ATN-224 (55), a copper chelator. To our delight, the fluorescence from this set of mice was indistinguishable from mice injected with CS790AM alone, confirming that the copper-induced fluorescence enhancements in vivo can be reversed by competitive copper chelation (Fig. 4) . Finally, we decreased basal levels of exchangeable copper in vivo by injecting mice with 5 mg∕kg ATN-224 2 h prior to injection of CS790AM. The fluorescence from chelator-treated mice was significantly lower than the signal from mice treated with CS790AM alone, indicating that CS790AM can detect basal, endogenous levels of labile copper in living mice.
After demonstrating the ability of CS790AM to detect copper fluctuations in vivo, we sought to determine the correlation between whole-animal copper imaging with CS790AM and copper detection in internal tissues by an independent method. To this end, we pretreated mice with CuCl 2 or PBS 2 h prior to CS790AM and obtained fluorescence images of the whole animals to verify the detection of copper in vivo (Fig. S6 ). Mice were then perfused, and subsequent imaging of their livers replicated the fluorescence increase seen in vivo following copper treatment (Fig. 4) . To quantitatively assess the total copper content in the livers, inductively coupled plasma mass spectrometry (ICP-MS) analysis was performed, which verified the copper increase seen after CuCl 2 injection (Fig. S6 ). Following these ex vivo studies, we sought to determine the lifetime of Cu þ detection by CS790AM in mice and the corresponding clearance time for the sensor. To this end, mice were pretreated with PBS or CuCl 2 2 h prior to treatment with CS790AM. Fluorescent imaging of these mice indicates that CS790AM has a robust response to Cu þ for up to 9 h after injection (Fig. 4) . Additionally, the fluorescent signal is fully attenuated within a few days (Fig. 4) , providing a valuable opportunity for longitudinal monitoring of copper in a single mouse. Alternatively, fluorescent imaging of mice following simultaneous injection of CuCl 2 and CS790AM did not show increased fluorescence in Cu 2þ treated animals, except for 12 h after the injections (Fig. S7) , which indicates that CS790AM is best used for detection of Cu þ levels that are present prior to dye injection. −∕− mouse model is particularly attractive owing to its phenotypic and metabolic similarities to Wilson disease in humans and its preparation by targeted inactivation of a single gene, which ensures that any disease phenotypes reflect only the consequences of the loss of ATP7B function (14, (56) (57) (58) . Specifically, a series of 7-to 11-wk-old WT and Atp7b −∕− female mice were injected with CS790AM and imaged at 5, 30, and 60 min after injection.
Comparison of fluorescent signals from the WT and Atp7b −∕− mice indicates that the knockout mice exhibit higher levels of fluorescence compared to the WT mice, with statistically significant differences 30 min after CS790AM injection (Fig. 5 ). These data are in agreement with fluorescence measurements of the serum of CS790AM treated Atp7b −∕− mice, which show increased CS790AM fluorescence compared to serum from heterozygote mice (Fig. S8) . Importantly, the fluorescent signal in the serum coelutes with copper during gel filtration, verifying the detection of copper by CS790AM, even in complex mixtures (Fig. S8 ). Additionally, a separate group of Atp7b −∕− mice was treated with vehicle or the copper chelator ATN-224, which is under development as a treatment for Wilson disease (55, 59). Following intraperitoneal injection of CS790AM, ex vivo imaging of livers from these mice indicates a decrease in fluorescence upon ATN-224 treatment ( Fig. 5 ) with a corresponding decrease in the fluorescence to copper ratio in the serum (Fig. S8 ). To illustrate that the liver is indeed a major organ of copper accumulation, ICP-MS analysis of tissues was completed. As shown in Fig. S9 , the Atp7b −∕− mice exhibit an expected increase in liver copper compared to WT counterparts, but copper levels do not differ significantly in other tissue types. The results are consistent with the dominant expression of ATP7B in liver tissue and its essential functions in hepatic copper efflux. Taken together, these data demonstrate the ability of CS790AM to monitor in vivo alterations in exchangeable copper levels that result from a disease state as well as decreased copper levels following ATN-224 treatment of Atp7b −∕− mice.
Concluding Remarks
The essential yet toxic nature of copper provides motivation for creating methods for noninvasive, real-time measurements of exchangeable, bioavailable copper pools in living systems. Whereas a growing number of chemical tools have been developed to probe copper biology at the cellular level, technologies that can illuminate the functions of this essential metal in whole animals remain limited. To meet this need, we have developed CS790, a first-generation near-IR turn-on fluorescent sensor for exchangeable copper stores in living cells and animals. Spectroscopic and live-cell imaging measurements establish the selectivity, sensitivity, and biological compatibility of the CS790 platform to monitor labile copper pools in vitro. Moreover, molecular imaging experiments in living mice clearly demonstrate the ability of CS790AM to report dynamic copper fluctuations in vivo and reveal that this probe is capable of detecting basal, endogenous levels of exchangeable copper in living mice. Notably, CS790AM has no apparent toxicity and is cleared from mice within a few days, thus providing the opportunity to monitor labile copper changes in a single mouse over time through various stages of health and disease. Indeed, additional work with a murine model of Wilson disease highlights the utility of CS790AM for detection of aberrant copper accumulation during pathological development, through the imaging of Atp7b −∕− mice. Additionally, CS790AM monitoring of chelation treatment in Atp7b −∕− mice further emphasizes the abilities of CS790AM for analysis of disease progression. Taken together, the results show that CS790AM can visualize fluctuations in bioavailable copper in living animals, affording a complementary technique to positron emission tomography of copper stores using radioactive 64 Cu (60, 61). The in vivo fluorescence detection of copper provided by CS790AM and related new chemical tools opens up unique opportunities to explore the roles that copper plays in healthy physiology as well as in the development and progression of disease.
Materials and Methods
Full materials and procedures for the synthesis of compounds, spectroscopic characterization, cellular imaging, and animal experiments are described in the SI Text. 41 
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2-Amino-5-Methoxybenzenethiol (2).
2-Amino-6-methoxy-benzothiazole, 1 (6.0 g, 33 mmol), was suspended in 50% KOH (30 g KOH dissolved in 30 mL water). The suspension was heated to reflux for 48 h. After cooling to room temperature, toluene (100 mL) was added and the reaction mixture was neutralized with acetic acid (30 mL). The organic layer was separated, and the aqueous layer was extracted with toluene (100 mL). The toluene layers were combined, washed with water, and dried over sodium sulfate (Na 2 SO 4 ). Evaporation of the solvent under reduced pressure gave the pure product (4.3 g, 83%) as a yellow solid. Propanoate (3). Acrylic acid (3.3 g, 35 mmol) was added to a solution of 2 (2.5 g, 16 mmol) in toluene (15 mL). The mixture was heated at reflux for 3 h prior to solvent removal via evaporation under reduced pressure. The residue was washed with diethyl ether (30 mL) and then dried in vacuo. Ethanol (30 mL) and concentrated sulfuric acid (0.5 mL) were added to the residue, and the mixture was heated at reflux for 24 h. After concentrating to approximately 5 mL, the mixture was suspended in water (80 mL). Saturated sodium bicarbonate solution (20 mL) was added to the mixture prior to extraction with ethyl acetate (EtOAc, 50 mL × 3). The combined organic layers were dried over Na 2 SO 4 and concentrated. Purification by silica gel column chromatography (EtOAchexane, 1∶2) afforded 3 (1.2 g, 20% 
4-Methoxy-N-(3-(Methylthio)Propyl)-2-((3-(Methylthio)Propyl)Thio)
Aniline (6) . Sodium thiomethoxide (0.85 g, 12.2 mmol) and 5 (1.2 g, 3.0 mmol) were dissolved in ethanol (100 mL), and the mixture was heated at reflux for 17 h under a nitrogen atmosphere. After concentration to 10 mL, water (100 mL) was added.
The mixture was extracted with dichloromethane (CH 2 Cl 2 , 50 mL × 3), and the combined organic layers were dried over Na 2 SO 4 and concentrated. Purification by column chromatography (EtOAc:hexane, 1∶4) afforded 6 (0.48 g, 48%) as a pale yellow oil. 
. To a solution of compound 6 (330 mg, 1.0 mmol) in CH 2 Cl 2 (10 mL, nitrogen-sparged) was added boron tribromide (100 μL, 3.0 mmol) at −78°C. The mixture was warmed to room temperature and stirred for 6 h. The reaction mixture was poured into crushed ice, and the organic layer was separated. The aqueous layer was extracted with CH 2 Cl 2 (20 mL × 2), and the combined organic layers were dried over Na 2 SO 4 and concentrated. (E)-2-Chloro-3-(Hydroxymethylene)Cyclohex-1-Enecarbaldehyde (9).
Synthesis of 9 was performed following a reported procedure (2) . Briefly, a solution of phosphorus oxychloride (POCl 3 , 37 mL, 400 mmol) in CH 2 Cl 2 (35 mL) was slowly added to an ice-cooled solution of dimethylformamide (DMF, 40 mL, 520 mmol) in CH 2 Cl 2 (40 mL). Following this addition, cyclohexanone, 8 (10 g, 100 mmol), was added dropwise. The resultant reaction mixture was heated at reflux for 2 h, prior to being cooled in ice. Water (200 mL) was added slowly while the mixture was stirred. Following water addition, the mixture was stirred for 1 h. The organic layer was collected and the water layer was extracted with additional CH 2 Cl 2 (40 mL × 3). The combined organic layers were dried over Na 2 SO 4 and concentrated. The residue was taken up in a mixture of EtOAc∶diethyl ether (3∶1) and washed with water (30 mL × 5) to remove the DMF. The combined organic layers were dried over Na 2 SO 4 and concentrated, and the residue was treated with pentane (200 mL) to give 4. IR780 Dicarboxylic Acid Derivative (12) . A mixture of 9 (1.6 g, 17 mmol), 11 (5.0 g, 33 mmol), and sodium acetate (2.6 g, 66 mmol) in acetic acid (100 mL) was heated at reflux for 20 h and then cooled to room temperature. The solution was concentrated, and the resulting residue was washed with diethyl ether (50 mL × 2). Coppersensor 790 (CS790). To a solution of 7 (200 mg, 0.63 mmol) in nitrogen-sparged DMF (10 mL) was added NaH (60% oil dispersion, 64 mg, 2.7 mmol). After stirring at room temperature for 10 min, 12 (360 mg, 0.53 mmol) was added. The mixture was stirred at room temperature for 12 h, and then water (1.0 mL) and 1.0 M HCl (2.6 mL) were successively added. The solvent was removed in vacuo, and the residue was purified by silica gel column chromatography (CH Spectroscopic Materials and Methods. All spectroscopic measurements were performed in 20 mM Hepes buffer, pH 7.0, prepared with Millipore water. Absorption spectra were recorded on a Varian Cary 50 spectrophotometer and fluorescence spectra were recorded on a Photon Technology International Quanta Master 4 L-format scan spectrofluorometer equipped with an LPS-220B 75-W xenon lamp and power supply, A-1010B lamp housing with integrated igniter, switchable 814 photocounting/analog photomultiplier detection unit, and MD5020 motor driver. Samples for absorption and emission measurements were contained in 0.35 × 1-cm quartz cuvettes (1.4-mL volume; Starna). Metals used in the selectivity assay were derived from their chloride or nitrate salts. A fluorescence quantum yield was determined by reference to Indocyanine Green (ICG) in DMSO (Φ ¼ 0.13) (3). The binding affinity of Cu þ to CS790 dye was measured using thiourea as a competitive ligand to provide a buffered Cu þ solution. Briefly, a 2 μM solution of CS790 was prepared in 20 mM Hepes, pH 7.0, and buffered with a known concentration of thiourea from a 500 mM stock solution in Millipore water. Cu þ was delivered in the form of ½CuðMeCNÞ 4 ½PF 6 from a stock solution (2 or 20 mM) prepared in acetonitrile (ACN). The maximum final ACN concentration was 0.1%. Stability constants for thiourea binding were taken from the literature: β 12 ¼ 2.0 × 10 12 , β 13 ¼ 2.0 × 10 14 , β 14 ¼ 3.4 × 10 15 (4). Excitation was provided at 730 nm. The apparent dissociation constant (K d ) was determined using the following equation:
where F is the observed fluorescence; F max is the fluorescence for the Cu þ :CS790 complex; F min is the fluorescence for CS790; and [Cu þ ] is the "free" Cu þ available for com-plexation, which was calculated using the stability constants for thiourea and standard competition equilibrium expressions.
Analysis of CS790AM
De-Esterification. To analyze the de-esterification of CS790AM within cells, approximately 500 million HEK 293Tcells grown in DMEM (Invitrogen) supplemented with 10% FBS (Invitrogen) and glutamine (2 mM) were trypsinized, washed with PBS (Thermo Scientific), and treated with CS790AM (2 μM, in DMEM) for 15 min. The cells were subsequently washed with PBS, lysed using milliQ H 2 O and sonication, and pelleted. The supernatant from the lysed cells was analyzed using liquid chromatography on an Agilent 6100 series single quad LC/MS system. Samples were run using 10 mM NH 4 OAc and acetonitrile with 0.05% formic acid as the mobile phase. Control runs and absorption spectra were collected for samples with 1 μM CS790 or CS790AM in H 2 O or 10% FBS in H 2 O, as well as a sample of 1 μM CS790AM incubated in a solution of 10% FBS for 15 min.
Cell Culture. HEK 293Tcells were cultured in DMEM supplemented with 10% FBS and glutamine (2 mM). Two days before imaging, cells were passed and plated on chamber slides (Lab-Tek; Thermo Fisher Scientific) or 12-mm glass coverslips coated with poly-L-lysine (50 mg∕mL; Sigma-Aldrich). For all experiments, a solution of CS790AM was made in DMEM or Dulbecco's phosphate buffered saline (DPBS; GIBCO) without calcium chloride, magnesium chloride, magnesium sulfate, sodium bicarbonate, or phenol red.
Flow Cytometry Experiments. Flow cytometry was performed with an LSRFortessa TM cell analyzer (BD Biosciences) equipped with a 640-nm red laser and PE-Cy7 band pass filter. Cells were cultured as described above prior to treatment with 5 μM CS790AM dye (from a 1 mM stock solution in DMSO) at 37°C, 5% CO 2 , for 15 min in DPBS. The cells were washed with DPBS, and then 150 μL of trypsin-EDTA solution (1×; GIBCO) was added. After incubation at 37°C, 5% CO 2 , for 5 min, 350 μL of DMEM containing 10% FBS was added to deactivate trypsin. To ensure complete removal of cells from coverslips, the solutions were drawn and released by pipette several times. The removed cells were transferred to a 1.5 mL eppendorf tube, and the tube was centrifuged (1;500 × g, 5 min). The supernatant was aspirated, and the cell pellets were suspended in 500 μL of DPBS containing 2% FBS. This process (suspension and centrifugation) was repeated three times. The washed cell pellet was suspended in 500 μL of DPBS and kept on ice. Gating was performed based on untreated live control cells, and a minimum of 10,000 live cells were gated per sample. Measurements were performed on three independent samples for each of three tested conditions (−Cu, +Cu, and +Cu+NS3′), with error bars representing the standard deviation of the mean. For copper addition experiments, 100 μM CuCl 2 was added to the cells 12 h prior to CS790AM addition from a 100 mM aqueous stock solution. For chelation experiments, 100 μM NS3′ (from a 100 mM stock in DMSO) was added with CS790AM. CuCl 2 was removed prior to CS790AM addition. Data were processed with FACSDiva software (BD Biosciences).
Confocal Fluorescence Imaging. Confocal fluorescence images were acquired with a Zeiss LSM510 META/NLO Axioplan 2 laser scanning microscope at the Molecular Imaging Center at the University of California, Berkeley or with a Zeiss LSM 710 laser scanning microscope. Experiments were performed with a 40× waterimmersion objective lens. Excitation of CS790AM-loaded cells at 633 nm was carried out with an argon ion laser, and emission was collected in a window over 650 nm using a META detection system. Excitation of Hoechst 33342 was carried out using a MaiTai two-photon laser at 780-nm pulses (36% laser power, modelocked Ti:sapphire laser; Tsunami Spectra Physics) and emission was collected between 452-538 nm. Live cell samples were incubated with a mixture of CS790AM (2 μM, from 1 mM stock in DMSO) and General Animal Imaging Methods and Data Analysis. A Xenogen IVIS Spectrum instrument (Caliper Life Sciences) was used for fluorescence imaging in all animal experiments, and image analysis was performed using the Living Image software. For image analysis of SKH-1 mice, regions of interest were drawn around the whole mouse and the total fluorescence signal was determined. For image analysis of Atp7b −∕− mice and harvested livers, the same size region of interest was used for all samples in a given experiment and the total fluorescence within the region of interest was determined. Mice were anesthetized prior to injection and during imaging via inhalation of isoflurane. PBS was purchased from Thermo Fisher Scientific, and isoflurane was purchased from Phoenix Pharmaceuticals, Inc. Sterile DMSO was purchased from Sigma-Aldrich, and medical-grade oxygen was purchased from Praxair. ) and ATN-224 (or vehicle) was performed while the mice were anesthetized, 2 h prior to injection of CS790AM (or vehicle). Following injection of CS790AM, mice were transferred to a Xenogen IVIS Spectrum (Caliper Life Sciences) and imaged 5 min after injection of CS790AM using a 745-nm excitation filter and a 800-nm emission filter. Mice used in clearance studies were injected with either CuCl 2 (i.p., 5 mg∕kg in 50 μL PBS) or PBS (i.p., 50 μL) and CS790AM (i.p., 0.1 mM in 50 μL of 7∶3 DMSO∶PBS). For one clearance study, the PBS or CuCl 2 was injected 2 h prior to the CS790AM, and for the other clearance study, the PBS or CuCl 2 was injected immediately prior to CS790AM. In both clearance studies, images of the mice were acquired 5, 30, and 60 min, 3, 6, 9, 12, 24, 36, 48, 60, and 72 h following injection of CS790AM. For ex vivo liver imaging, SKH-1 mice were injected with either CuCl 2 (i.p., 5 mg∕kg in 50 μL PBS) or PBS (i.p., 50 μL) 2 h prior to CS790AM (i.p., 0.1 mM in 50 μL of 7∶3 DMSO∶PBS). Images of the mice were acquired 5, 30, and 60 min after CS790AM injection. Following in vivo imaging, mice were anesthetized, perfused with PBS, and their livers were harvested and imaged.
Imaging Experiments with Atp7b −∕− Mice. Seven-to 11-wk-old Atp7b −∕− mice and their wild-type littermates had the hair on their ventral surface removed using a hair trimmer and a depilatory cream (Nair) to allow detection of the fluorescent signal from CS790AM. Following fur removal, the mice were anesthetized with isoflurane and injected with CS790AM (i.p., 0.1 mM in 50 μL of 7∶3 DMSO∶PBS). Mice were then transferred to a Xenogen IVIS Spectrum instrument and imaged using a 745-nm excitation filter and an 800-nm emission filter 5, 30, and 60 min after CS790AM injection.
Tissue Harvesting and Inductively Coupled Plasma (ICP)-MS. Mice were heavily anesthetized and slowly perfused with PBS (10-25 mL). Following perfusion, tissues were harvested and immediately placed on dry ice in cryotubes or on ice in Petri dishes. For fluorescence analysis, tissues were imaged in a Xenogen IVIS Spectrum instrument. For ICP-MS analysis, portions of the harvested tissues were digested in concentrated nitric acid (HNO 3 ) at 90°C for 2 h. After overnight incubation at room temperature, samples were diluted with 2% HNO 3 , doped with Galium (the internal standard), and the copper content was determined using a Perkin Elmer Sciex Eland DRCII ICP-MS in the standard mode at the Earth Sciences Division, Lawrence Berkeley National Laboratory.
Serum Collection and Gel Filtration Chromatography. Heterozygous Atp7b þ∕− mice do not show disease phenotype or liver copper misbalance and have been used in our experiments as a control interchangeably with wild-type Atp7b þ∕þ mice. Atp7b −∕− and heterozygous mice were treated with ATN-224 (i.p., 5 mg∕kg in 50 μL PBS) or vehicle 2 h prior to injection of CS790AM (i.p., 0.1 mM in 50 μL of 7∶3 DMSO∶PBS). Following dye injection, mice were anesthetized with isoflurane and blood was obtained by drainage from a small incision in the right atrium. Serum was collected by centrifuging blood at 4;000 × g for 10 min at 4°C. One hundred microliters of serum was loaded onto a size-exclusion column (Phenomenex Bio-Sep S-2000; 7.5 × 200, 10 μM), equilibrated with 50 mM sodium phosphate buffer, pH 7.5. Samples were fractionated isocratically with the same buffer at a flow rate of 0.250 mL per min, and 0.250 mL fractions were collected over 80 min. Absorbance was monitored at 215 and 280 nm. Calibration of size-exclusion column was done using molecular weight standards [Bio-Rad: Thyroglobulin (670KDa), γ-globulin (158 KDa), Ovalbumin (44 KDa), Myoglobin (17 KDa), Vitamin B12 (1,350 Da)], reduced L-glutathione (307 Da), tryptophan (ca. 204 Da), and copper chloride (ca. 64 Da). All standards were prepared in 50 mM sodium phosphate buffer, pH 7.5. Collected fractions were placed in a clear-bottom, 96-well plate (BD Falcon) and fluorescence was measured on a Gemini EM plate reader (Molecular Devices). Excitation wavelength was 730 nm and emission was read at 790 nm.
Atomic Absorption Spectroscopy. The copper concentration of the serum and serum fractions collected during gel filtration was determined using a Shimadzu 6650 graphite furnace atomic absorption spectrophotometer equipped with an ASC-6100 autosampler. Briefly, samples were diluted with ddH 2 O (1∶30 or 1∶200 for fractionated and unfractionated serum, respectively) to remain in the linear absorption range of the calibration curve (1-10 parts per billion). Each sample was measured two to three times, and the concentration of copper was determined with a calibration curve. All values are reported as means. S3 . Analysis of CS790AM de-esterification in cells. HEK 293T cells were incubated with CS790AM (2 μM) for 15 min, washed with PBS, lysed, and analyzed by liquid chromatography. Graphs are the absorbance trace at 760 nm of various samples. Control runs with CS790AM and CS790 in water indicate the retention times for the two compounds (A and B, respectively). Control runs with CS790AM and CS790 in 10% FBS indicate the retention times for the two compounds in the presence of FBS (C and D, respectively). These graphs are compared with traces from CS790AM incubated with 10% FBS or with HEK 293T cells for 15 min (E and F, respectively), which indicates that the CS790AM esters are stable in the presence of serum, but cleaved within cells. The background absorbance for the graphs changes over the first minute due to an increase in the percent organic solvent in the eluent over this time. 
